Download
12872_2024_Article_3927.pdf 1,31MB
WeightNameValue
1000 Titel
  • Epicardial fat volume is associated with primary coronary slow-flow phenomenon in patients with severe aortic stenosis undergoing transcatheter valve implantation
1000 Autor/in
  1. Weferling, Maren |
  2. Rolf, Andreas |
  3. Treiber, Julia |
  4. Fischer-Rasokat, Ulrich |
  5. Liebetrau, Christoph |
  6. Hamm, Christian W. |
  7. Dey, Damini |
  8. Kim, Won-Keun |
1000 Verlag
  • BioMed Central
1000 Erscheinungsjahr 2024
1000 Publikationstyp
  1. Artikel |
1000 Online veröffentlicht
  • 2024-05-16
1000 Erschienen in
1000 Quellenangabe
  • 24(1):253
1000 Copyrightjahr
  • 2024
1000 Lizenz
1000 Verlagsversion
  • https://doi.org/10.1186/s12872-024-03927-7 |
  • https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11097472/ |
1000 Publikationsstatus
1000 Begutachtungsstatus
1000 Sprache der Publikation
1000 Abstract/Summary
  • <jats:title>Abstract</jats:title><jats:sec><jats:title>Background</jats:title><jats:p>Primary coronary slow flow (CSF) is defined as delayed opacification of the distal epicardial vasculature during coronary angiography in the absence of relevant coronary artery stenoses. Microvascular disease is thought to be the underlying cause of this pathology. Epicardial fat tissue (EFT) is an active endocrine organ directly surrounding the coronary arteries that provides pro-inflammatory factors to the adjacent tissue by paracrine and vasocrine mechanisms. The aim of the present study was to investigate a potential association between EFT and primary CSF and whether EFT can predict the presence of primary CSF.</jats:p></jats:sec><jats:sec><jats:title>Methods</jats:title><jats:p>Between 2016 and 2017,<jats:italic>n</jats:italic> = 88 patients with high-grade aortic stenosis who were planned for transcatheter aortic valve implantation (TAVI) were included in this retrospective study. EFT volume was measured by pre-TAVI computed tomography (CT) using dedicated software. The presence of primary CSF was defined based on the TIMI frame count from the pre-TAVI coronary angiograms.</jats:p></jats:sec><jats:sec><jats:title>Results</jats:title><jats:p>Thirty-nine of 88 TAVI patients had CSF (44.3%). EFT volume was markedly higher in patients with CSF (142 ml [IQR 107–180] vs. 113 ml [IQR 89–147];<jats:italic>p</jats:italic> = 0.009) and was strongly associated with the presence of CSF (OR 1.012 [95%CI 1.002–1.021];<jats:italic>p</jats:italic> = 0.014). After adjustment, EFT volume was still an independent predictor of CSF (OR 1.016 [95%CI 1.004–1.026];<jats:italic>p</jats:italic> = 0.009).</jats:p></jats:sec><jats:sec><jats:title>Conclusion</jats:title><jats:p>Primary CSF was independently associated with increased EFT volume. Further studies are needed to validate this finding and elucidate whether a causal relationship exists.</jats:p></jats:sec>
1000 Sacherschließung
lokal Aortic Valve/physiopathology [MeSH]
lokal Coronary Vessels/diagnostic imaging [MeSH]
lokal Aged, 80 and over [MeSH]
lokal Aged [MeSH]
lokal Pericardium/diagnostic imaging [MeSH]
lokal Aortic Valve/surgery [MeSH]
lokal Risk Factors [MeSH]
lokal Coronary slow- flow
lokal Adipose Tissue/diagnostic imaging [MeSH]
lokal Male [MeSH]
lokal TIMI frame count
lokal Computed Tomography Angiography [MeSH]
lokal Aortic Valve Stenosis/physiopathology [MeSH]
lokal Aortic Valve Stenosis/surgery [MeSH]
lokal Aortic Valve Stenosis/diagnostic imaging [MeSH]
lokal Female [MeSH]
lokal Aortic Valve/diagnostic imaging [MeSH]
lokal Epicardial Adipose Tissue [MeSH]
lokal Humans [MeSH]
lokal Severity of Illness Index [MeSH]
lokal Treatment Outcome [MeSH]
lokal Predictive Value of Tests [MeSH]
lokal Retrospective Studies [MeSH]
lokal Transcatheter Aortic Valve Replacement/adverse effects [MeSH]
lokal Aortic Valve/pathology [MeSH]
lokal Coronary Circulation [MeSH]
lokal Coronary Angiography [MeSH]
lokal Research
lokal Epicardial fat tissue
lokal TAVI
lokal Coronary Vessels/physiopathology [MeSH]
lokal Adipose Tissue/physiopathology [MeSH]
1000 Fächerklassifikation (DDC)
1000 Liste der Beteiligten
  1. https://frl.publisso.de/adhoc/uri/V2VmZXJsaW5nLCBNYXJlbg==|https://frl.publisso.de/adhoc/uri/Um9sZiwgQW5kcmVhcw==|https://frl.publisso.de/adhoc/uri/VHJlaWJlciwgSnVsaWE=|https://frl.publisso.de/adhoc/uri/RmlzY2hlci1SYXNva2F0LCBVbHJpY2g=|https://frl.publisso.de/adhoc/uri/TGllYmV0cmF1LCBDaHJpc3RvcGg=|https://frl.publisso.de/adhoc/uri/SGFtbSwgQ2hyaXN0aWFuIFcu|https://frl.publisso.de/adhoc/uri/RGV5LCBEYW1pbmk=|https://frl.publisso.de/adhoc/uri/S2ltLCBXb24tS2V1bg==
1000 Hinweis
  • DeepGreen-ID: 8d82d3841ca74e1aafe0895886b6475c ; metadata provieded by: DeepGreen (https://www.oa-deepgreen.de/api/v1/), LIVIVO search scope life sciences (http://z3950.zbmed.de:6210/livivo), Crossref Unified Resource API (https://api.crossref.org/swagger-ui/index.html), to.science.api (https://frl.publisso.de/), ZDB JSON-API (beta) (https://zeitschriftendatenbank.de/api/), lobid - Dateninfrastruktur für Bibliotheken (https://lobid.org/resources/search)
1000 Label
1000 Förderer
  1. Justus-Liebig-Universität Gießen |
1000 Fördernummer
  1. -
1000 Förderprogramm
  1. -
1000 Dateien
1000 Förderung
  1. 1000 joinedFunding-child
    1000 Förderer Justus-Liebig-Universität Gießen |
    1000 Förderprogramm -
    1000 Fördernummer -
1000 Objektart article
1000 Beschrieben durch
1000 @id frl:6523168.rdf
1000 Erstellt am 2025-07-06T19:46:44.206+0200
1000 Erstellt von 322
1000 beschreibt frl:6523168
1000 Zuletzt bearbeitet 2025-07-29T19:16:22.291+0200
1000 Objekt bearb. Tue Jul 29 19:16:22 CEST 2025
1000 Vgl. frl:6523168
1000 Oai Id
  1. oai:frl.publisso.de:frl:6523168 |
1000 Sichtbarkeit Metadaten public
1000 Sichtbarkeit Daten public
1000 Gegenstand von

View source